Enveric Biosciences, Inc. held a Special Meeting of Stockholders on December 11, 2025, where they voted on issuing shares, a reverse stock split, and increasing authorized shares, with significant support for most proposals. The voting results included 1,896,330 votes for the reverse stock split and 1,946,233 for increasing authorized shares.